A detailed history of Kohmann Bosshard Financial Services, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Kohmann Bosshard Financial Services, LLC holds 2,500 shares of NUVB stock, worth $5,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Holding current value
$5,950
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$2.01 - $3.01 $5,024 - $7,524
2,500 New
2,500 $6,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $517M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Kohmann Bosshard Financial Services, LLC Portfolio

Follow Kohmann Bosshard Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kohmann Bosshard Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kohmann Bosshard Financial Services, LLC with notifications on news.